Impact of Nausea and Vomiting on Quality of Life in Cancer Patients During Chemotherapy
Open Access
- 1 January 2003
- journal article
- review article
- Published by Springer Science and Business Media LLC in Health and Quality of Life Outcomes
- Vol. 1 (1), 46
- https://doi.org/10.1186/1477-7525-1-46
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Dexamethasone Alone or in Combination with Ondansetron for the Prevention of Delayed Nausea and Vomiting Induced by ChemotherapyThe New England Journal of Medicine, 2000
- Effects of anti‐emetic drug (tropisetron) on quality of life during chemotherapy: Use of a diary‐type questionnaire and application of summary measures for assessment in a randomized, multicentre studyRespirology, 1999
- Effect of postchemotherapy nausea and vomiting on health-related quality of lifeSupportive Care in Cancer, 1997
- Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of lifeClinical Therapeutics, 1996
- On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993Annals Of Oncology, 1996
- Oral ondansetron in the prevention of chemotherapy-induced emesis in breast cancer patientsEuropean Journal of Cancer, 1995
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Quality of life consequences of chemotherapy-induced emesisQuality of Life Research, 1992
- Ondansetron Compared with Metoclopramide in the Control of Emesis and Quality of Life during Repeated Chemotherapy for Breast CancerOncology, 1992
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983